Mateo Marin-Cuartas: What Matters After Aortic Valve Replacement in Younger Patients?
Mateo Marin-Cuartas, Cardiac Surgeon at German Heart Center of the Charité, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in EHJ – Valvular and Structural Heart Disease, adding:
“Beyond survival: how should we interpret patient-reported outcomes and health status after aortic valve replacement in younger patients?
In our new publication in the European Heart Journal – Valvular and Structural Heart Disease (EHJVSHD) from European Society of Cardiology, Milan Milojevic, Nikolaos Bonaros and I discuss the latest NOTION-2 health-status analysis comparing TAVI and SAVR in younger, low-risk patients.
Some important messages:
- At 3 years, patient-reported outcomes are similarly favorable after TAVI and SAVR. But for a younger patient, 3 years is a milestone-not the final destination.
- Quality of life matters. But so do durability, reintervention, major clinical events, coronary access, and future treatment options.
- The real challenge: achieving not only a good recovery today, but durable health and quality of life over a lifetime.
Special thanks to Prof. Marco Metra EiC of EHJVSHD, for the invitation to contribute with this editorial comment.”
Title: Beyond survival: how should we interpret patient-reported outcomes and health status after aortic valve replacement in younger patients?
Authors: Mateo Marin-Cuartas, Milan Milojevic, Nikolaos Bonaros

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines